NCT05670054 2023-01-04
Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients
Mansoura University
Phase 3 Unknown
Mansoura University
Beneficência Portuguesa de São Paulo
Instituto Brasileiro de Controle do Cancer